Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
CC transcript
Quarterly results
Director departure

Pharmasset Inc (VRUS) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/12/2013 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2012 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/13/2012 SC 13G/A Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
02/09/2012 SC 13G Pharmasset Inc reports a 6% stake in PHARMASSET INC
02/02/2012 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals
01/19/2012 15-12B Form 15-12B - Securities registration termination [Section 12(b)]
01/19/2012 EFFECT Form EFFECT - Notice of Effectiveness
01/19/2012 EFFECT Form EFFECT - Notice of Effectiveness
01/19/2012 EFFECT Form EFFECT - Notice of Effectiveness
01/19/2012 EFFECT Form EFFECT - Notice of Effectiveness
01/17/2012 4/A Williamson Robert F III (Director) has filed a Form 4 on Pharmasset Inc
Txns: Disposed/sold 15,000 options to buy @ $83.52, valued at $1.3M
01/17/2012 4 Form 4 - Statement of changes in beneficial ownership of securities
01/17/2012 4 INOUYE MICHAEL K (Director) has filed a Form 4 on Pharmasset Inc
01/17/2012 4 HAHN ELLIOT F (Director) has filed a Form 4 on Pharmasset Inc
01/17/2012 4 Carney William J (Director) has filed a Form 4 on Pharmasset Inc
01/17/2012 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
01/17/2012 4 Williamson Robert F III (Director) has filed a Form 4 on Pharmasset Inc
01/17/2012 4 LEUTZINGER KURT (CFO) has filed a Form 4 on Pharmasset Inc
Txns: Unknown transaction of 222,232 shares @ $137, valued at $30.4M
Unknown transaction of 75,300 shares @ $137, valued at $10.3M
Unknown transaction of 75,300 shares @ $137, valued at $10.3M
Disposed/sold 125,000 options to buy @ $1.5, valued at $187.5k
Disposed/sold 68,500 options to buy @ $1.94, valued at $132.9k
Disposed/sold 51,000 options to buy @ $2.01, valued at $102.5k
Disposed/sold 62,000 options to buy @ $6.84, valued at $424.1k
Disposed/sold 20,000 options to buy @ $9.3, valued at $186k
Disposed/sold 50,000 options to buy @ $10.83, valued at $541.5k
Disposed/sold 59,000 options to buy @ $16.17, valued at $954k
Disposed/sold 75,000 options to buy @ $83.52, valued at $6.3M
01/17/2012 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
01/17/2012 4 Berrey M Michelle (Chief Medical Officer) has filed a Form 4 on Pharmasset Inc
01/17/2012 8-K Quarterly results
01/17/2012 4 Price P Schaefer (President and CEO) has filed a Form 4 on Pharmasset Inc
01/17/2012 4 OTTO MICHAEL J. (Chief Scientific Officer) has filed a Form 4 on Pharmasset Inc
01/17/2012 4 Rogers Michael D. (Chief Development Officer) has filed a Form 4 on Pharmasset Inc
01/13/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/12/2012 8-K Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain O...
01/12/2012 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
12/27/2011 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
12/22/2011 8-K Form 8-K - Current report
12/20/2011 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
12/16/2011 8-K Other Events, Financial Statements and Exhibits
Docs: "Pharmasset Announces Intent to Amend QUANTUM Trial"
12/16/2011 PRN Pharmasset Announces Intent to Amend QUANTUM Trial
12/06/2011 SC TO-T/A Form SC TO-T - Tender offer statement by Third Party [amend]
12/06/2011 SC 14D9 Form SC 14D9 - Solicitation, recommendation statements
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy